findmyKOL
Clinical trialNCT00053105UnknownPhase 1Interventional

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

SponsorTheradexLymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase I trial to study the effect of combination chemotherapy on the body when treating patients who have relapsed or refractory aggressive non-Hodgkin's lymphoma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Clinical Research Center

    Tucson, Arizona, United States

  • Highlands Oncology Group

    Springdale, Arkansas, United States

  • Usc/norris Comprehensive Cancer Center and Hospital

    Los Angeles, California, United States

  • Marlene and Stewart Greenebaum Cancer Center, University of Maryland

    Baltimore, Maryland, United States

  • Ireland Cancer Center

    Cleveland, Ohio, United States

  • Boston Baskin Cancer Group, University Tennessee

    Memphis, Tennessee, United States

  • University of Texas - Md Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cisplatin →Cytarabine →Methylprednisolone →Pixantrone dimaleate
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2002
Primary completion
—
Completion
—
Last update posted
7 Jul 2009
Registered enrollment
—
Registry id
NCT00053105
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.